Clinical trial
Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction…
NCT00317694 · Ineos Healthcare Limited, Industry · Completed
Key facts
| NCT number | NCT00317694 |
|---|---|
| Title | Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients |
| Official title | A Multicentre Phase II Study With Magnesium Iron Hydroxycarbonate: an Open-label, Dose-ranging Phase Followed by a Placebo-controlled, Double-blind, Parallel-group Comparison in Haemodialysis Subjects With Hyperphosphataemia |
| Lead sponsor | Ineos Healthcare Limited, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Kidney Failure |
| Intervention type | Drug |
| Interventions | Fermagate, Placebo |
| Enrollment | 111 |
| Start date | Mar 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Apr 25, 2006 |
| Last update posted | Aug 10, 2009 |
| Countries | United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: